These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1160 related items for PubMed ID: 31046570

  • 21. Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus.
    Kwon OC, Ghang B, Lee EJ, Hong S, Lee CK, Yoo B, Kim S, Kim YG.
    Int J Rheum Dis; 2019 Jul; 22(7):1305-1311. PubMed ID: 30941928
    [Abstract] [Full Text] [Related]

  • 22. Identification of Low-Abundance Urinary Biomarkers in Lupus Nephritis Using Electrochemiluminescence Immunoassays.
    Stanley S, Mok CC, Vanarsa K, Habazi D, Li J, Pedroza C, Saxena R, Mohan C.
    Arthritis Rheumatol; 2019 May; 71(5):744-755. PubMed ID: 30618193
    [Abstract] [Full Text] [Related]

  • 23. Serum and Urine Monocyte Chemoattractant Protein-1 as A Markers for Lupus Nephritis.
    Abozaid MA, Ahmed GH, Tawfik NM, Sayed SK, Ghandour AM, Madkour RA.
    Egypt J Immunol; 2020 Jan; 27(1):97-107. PubMed ID: 33180392
    [Abstract] [Full Text] [Related]

  • 24. Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4.
    Julkunen H, Ekblom-Kullberg S, Miettinen A.
    Rheumatol Int; 2012 Aug; 32(8):2445-51. PubMed ID: 21706294
    [Abstract] [Full Text] [Related]

  • 25. Plasma soluble tumor necrosis factor receptor I as a biomarker of lupus nephritis and disease activity in systemic lupus erythematosus patients.
    Liu XR, Qi YY, Zhao YF, Cui Y, Zhao ZZ.
    Ren Fail; 2023 Dec; 45(1):2174355. PubMed ID: 36946374
    [Abstract] [Full Text] [Related]

  • 26. Urinary Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (uTWEAK) and Urinary Monocyte Chemo-attractant Protein-1 (uMCP-1): Promising Biomarkers of Lupus Nephritis Activity?
    Elsaid DS, Abdel Noor RA, Shalaby KA, Haroun RA.
    Saudi J Kidney Dis Transpl; 2021 Dec; 32(1):19-29. PubMed ID: 34145111
    [Abstract] [Full Text] [Related]

  • 27. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA, El-Gendi HI, Ahmed HH.
    Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
    [Abstract] [Full Text] [Related]

  • 28. Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients.
    He D, Liu M, Liu B.
    Tohoku J Exp Med; 2018 Apr; 244(4):263-270. PubMed ID: 29576585
    [Abstract] [Full Text] [Related]

  • 29. Serum Levels of CXCL10 and Vitamin D in Patients with Lupus Nephritis.
    Abediazar S, Jafari-Nakhjavani M, Ghorbanihaghjo A, Shekarchi M, Zununi Vahed S.
    Iran J Kidney Dis; 2019 Nov; 13(6):389-397. PubMed ID: 31880585
    [Abstract] [Full Text] [Related]

  • 30. Soluble Flt-1, Placental Growth Factor, and Vascular Endothelial Growth Factor Serum Levels to Differentiate Between Active Lupus Nephritis During Pregnancy and Preeclampsia.
    de Jesús GR, Lacerda MI, Rodrigues BC, Dos Santos FC, do Nascimento AP, Cristóvão Porto L, de Jesús NR, Levy RA, Klumb EM.
    Arthritis Care Res (Hoboken); 2021 May; 73(5):717-721. PubMed ID: 32583963
    [Abstract] [Full Text] [Related]

  • 31. Monocyte chemoattractant-1 as a urinary biomarker for the diagnosis of activity of lupus nephritis in Brazilian patients.
    Rosa RF, Takei K, Araújo NC, Loduca SM, Szajubok JC, Chahade WH.
    J Rheumatol; 2012 Oct; 39(10):1948-54. PubMed ID: 22942263
    [Abstract] [Full Text] [Related]

  • 32. Urinary B-cell-activating factor of the tumour necrosis factor family (BAFF) in systemic lupus erythematosus.
    Vincent FB, Kandane-Rathnayake R, Hoi AY, Slavin L, Godsell JD, Kitching AR, Harris J, Nelson CL, Jenkins AJ, Chrysostomou A, Hibbs ML, Kerr PG, Rischmueller M, Mackay F, Morand EF.
    Lupus; 2018 Nov; 27(13):2029-2040. PubMed ID: 30301439
    [Abstract] [Full Text] [Related]

  • 33. Serum thiols as a biomarker of disease activity in lupus nephritis.
    Lalwani P, de Souza GK, de Lima DS, Passos LF, Boechat AL, Lima ES.
    PLoS One; 2015 Nov; 10(3):e0119947. PubMed ID: 25799079
    [Abstract] [Full Text] [Related]

  • 34. Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis.
    Urrego T, Ortiz-Reyes B, Vanegas-García AL, Muñoz CH, González LA, Vásquez G, Gómez-Puerta JA.
    Reumatol Clin (Engl Ed); 2020 Nov; 16(1):17-23. PubMed ID: 29530762
    [Abstract] [Full Text] [Related]

  • 35. Measurement of urinary chemokine and growth factor messenger RNAs: a noninvasive monitoring in lupus nephritis.
    Avihingsanon Y, Phumesin P, Benjachat T, Akkasilpa S, Kittikowit V, Praditpornsilpa K, Wongpiyabavorn J, Eiam-Ong S, Hemachudha T, Tungsanga K, Hirankarn N.
    Kidney Int; 2006 Feb; 69(4):747-53. PubMed ID: 16518330
    [Abstract] [Full Text] [Related]

  • 36. Urinary monocyte chemoattractant protein-1 correlates with disease activity in lupus nephritis.
    Marks SD, Shah V, Pilkington C, Tullus K.
    Pediatr Nephrol; 2010 Nov; 25(11):2283-8. PubMed ID: 20683619
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Urinary TWEAK and the activity of lupus nephritis.
    Schwartz N, Su L, Burkly LC, Mackay M, Aranow C, Kollaros M, Michaelson JS, Rovin B, Putterman C.
    J Autoimmun; 2006 Dec; 27(4):242-50. PubMed ID: 17257812
    [Abstract] [Full Text] [Related]

  • 39. Urinary monocyte chemoattractant protein 1 and alpha 1 acid glycoprotein as biomarkers of renal disease activity in juvenile-onset systemic lupus erythematosus.
    Watson L, Midgley A, Pilkington C, Tullus K, Marks S, Holt R, Jones C, Beresford M.
    Lupus; 2012 Apr; 21(5):496-501. PubMed ID: 22147846
    [Abstract] [Full Text] [Related]

  • 40. Measurement of interleukin-1 receptor antagonist in patients with systemic lupus erythematosus could predict renal manifestation of the disease.
    Brugos B, Kiss E, Dul C, Gubisch W, Szegedi G, Sipka S, Zeher M.
    Hum Immunol; 2010 Sep; 71(9):874-7. PubMed ID: 20538031
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 58.